Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Hepatology. 2011 May 1;53(5):1618–1628. doi: 10.1002/hep.24239

Figure 8. Alb-Cre Ron TKfl/fl and Ron TKfl/fl mice have a survival advantage over Lys-Cre Ron TKfl/fl mice treated with LPS/GalN.

Figure 8

(A) Kaplan-Meier survival graph of mice injected with LPS/GalN. Lys-Cre Ron TKfl/fl n=5, Ron TKfl/fl n=8, Alb-Cre Ron TKfl/fl n=6. Survival of the Lys-Cre Ron TKfl/fl mice was significantly less than the other two groups. Logrank test P=0.005. (B) Comparison of survival times in hours. *P<0.05 between Alb-Cre and Lys-Cre mice.